Blood-Brain Barrier Modulations and Low-Level Exposure to Xenobiotics

Chemical Warfare Agents: Toxicity at Low Levels

Volumn , Issue , 2000, Pages 121-144

  Soreq, Hermona ^a   Kaufer, Daniela ^a   Friedman, Alon ^b   Glick, David ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006231465     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420041576-7     Document Type: Chapter

References (115)

1. Pardridge, W.M., Connor, J.D., and Crawford, I.L., Permeability changes in the bloodbrain barrier: Causes and consequences, CRC Crit. Rev. Toxicol., 3(2), 159, 1975.
2. Rubin, L.L. and Staddon, J.M., The cell biology of the blood-brain barrier, Ann. Rev. Neurosci., 22, 11, 1999.
3. Pardridge, W.M., CNS drug design based on principles of blood-brain barrier transport, J. Neurochem., 70(5), 1781, 1998.
4. Gross, P.M., Circumventricular organ capillaries, Prog. Brain. Res., 91, 219, 1992.
5. Risau, W., Differentiation of endothelium, FASEB J., 9(10), 926, 1995.
6. Schinkel, A.H., Smit, J.J., van Tellingen, O., Beijnen, J.H., Wagenaar, E., van Deemter, L., Mol, C.A., van der Valk, M.A., Robanus-Maandag, E.C., te Riele, H.P., et al., Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the bloodbrain barrier and to increased sensitivity to drugs, Cell, 77(4), 491, 1994.
7. Dejana, E., Corada, M., and Lampugnani, M.G., Endothelial cell-to-cell junctions, FASEB J., 9(10), 910, 1995.
8. Gumbiner, B.M., Cell adhesion: The molecular basis of tissue architecture and morphogenesis, Cell, 84(3), 345, 1996.
9. Lum, H. and Malik, A.B., Regulation of vascular endothelial barrier function, Am. J. Physiol., 267(3 Pt 1), L223, 1994.
10. Staddon, J.M. and Rubin, L.L., Cell adhesion, cell junctions and the blood-brain barrier, Curr. Opin. Neurobiol., 6(5), 622, 1996.
11. Balda, M.S., Gonzalez-Mariscal, L., Matter, K., Cereijido, M., and Anderson, J.M., Assembly of the tight junction: The role of diacylglycerol, J. Cell Biol., 123(2), 293, 1993.
12. Anderson, J.M. and Van Itallie, C.M., Tight junctions and the molecular basis for regulation of paracellular permeability, Am. J. Physiol., 269(4 Pt 1), G467, 1995.
13. Citi, S., Sabanay, H., Jakes, R., Geiger, B., and Kendrick-Jones, J., Cingulin, a new peripheral component of tight junctions, Nature, 333(6170), 272, 1988.
14. Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., and Tsukita, S., Occludin: A novel integral membrane protein localizing at tight junctions, J. Cell Biol., 123(6 Pt 2), 1777, 1993.
15. Nusrat, A., Giry, M., Turner, J.R., Colgan, S.P., Parkos, C.A., Carnes, D., Lemichez, E., Boquet, P., and Madara, J.L., Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia, Proc. Natl. Acad. Sci. U.S.A., 92(23), 10629, 1995.
16. Grifman, M., Galyam, N., Seidman, S., and Soreq, H., Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis, Proc. Natl. Acad. Sci. U.S.A., 95(23), 13935, 1998.
17. Thoreson, M.A., Anastasiadis, P.Z., Daniel, J.M., Ireton, R.C., Whellock, M.J., Johnson, K.R., Hummingbird, D.K., and Reynolds, A.B., Selective uncoupling of p120ctn from E-cadhedrin disrupts strong adhesion, J. Cell Biol., 148(1), 189, 2000.
18. Adamson, P., Etienne, S., Couraud, P.O., Calder, V., and Greenwood, J., Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway, J. Immunol., 162(5), 2964, 1999.
19. Ratcliffe, M.J., Rubin, L.L., and Staddon, J.M., Dephosphorylation of the cadherinassociated p100/p120 proteins in response to activation of protein kinase C in epithelial cells, J. Biol. Chem., 272(50), 31894, 1997.
20. Irie, M., Hata, Y., Takeuchi, M., Ichtchenko, K., Toyoda, A., Hirao, K., Takai, Y., Rosahl, T.W., and Sudhof, T.C., Binding of neuroligins to PSD-95, Science, 277(5331), 1511, 1997.
21. Tang, T., Frenette, P.S., Hynes, R.O., Wagner, D.D., and Mayadas, T.N., Cytokineinduced meningitis is dramatically attenuated in mice deficient in endothelial selectins, J. Clin. Invest., 97(11), 2485, 1996.
22. Auld, V.J., Fetter, R.D., Broadie, K., and Goodman, C.S., Gliotactin, a novel transmembrane protein on peripheral glia, is required to form the blood-nerve barrier in Drosophila, Cell, 81(5), 757, 1995.
23. Baumgartner, S., Littleton, J.T., Broadie, K., Bhat, M.A., Harbecke, R., Lengyel, J.A., Chiquet-Ehrismann, R., Prokop, A., and Bellen, H.J., A Drosophila neurexin is required for septate junction and blood-nerve barrier formation and function, Cell, 87(6), 1059, 1996.
24. Darboux, I., Barthalay, Y., Piovant, M., and Hipeau-Jacquotte, R., The structure-function relationships in Drosophila neurotactin show that cholinesterasic domains may have adhesive properties, EMBO J., 15(18), 4835, 1996.
25. Grisaru, D., Sternfeld, M., Eldor, A., Glick, D., and Soreq, H., Structural roles of acetylcholinesterase variants in biology and pathology, Eur. J. Biochem., 264(3), 672, 1999.
26. Kaufer, D., Friedman, A., Seidman, S., and Soreq, H., Acute stress facilitates long-lasting changes in cholinergic gene expression, Nature, 393(6683), 373, 1998.
27. Fanning, A.S. and Anderson, J.M., Protein-protein interactions: PDZ domain networks, Curr. Biol., 6(11), 1385, 1996.
28. Saras, J. and Heldin, C.H., PDZ domains bind carboxy-terminal sequences of target proteins, Trends Biochem. Sci., 21(12), 455, 1996.
29. Bhat, M.A., Izaddoost, S., Lu, Y., Cho, K.O., Choi, K.W., and Bellen, H.J., Discs lost, a novel multi-PDZ domain protein, establishes and maintains epithelial polarity, Cell, 96(6), 833, 1999.
30. Janzer, R.C. and Raff, M.C., Astrocytes induce blood-brain barrier properties in endothelial cells, Nature, 325(6101), 253, 1987.
31. Bellen, H.J., Lu, Y., Beckstead, R., and Bhat, M.A., Neurexin IV, caspr and paranodin- novel members of the neurexin family: Encounters of axons and glia, Trends Neurosci, 21(10), 444, 1998.
32. Wolburg, H., Neuhaus, J., Kniesel, U., Krauss, B., Schmid, E.M., Ocalan, M., Farrell, C., and Risau, W., Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes, J. Cell Sci., 107(Pt 5), 1347, 1994.
33. Schroeter, M.L., Mertsch, K., Giese, H., Muller, S., Sporbert, A., Hickel, B., and Blasig, I.E., Astrocytes enhance radical defence in capillary endothelial cells constituting the blood-brain barrier, FEBS Lett., 449(2-3), 241, 1999.
34. Granholm, A.C., Curtis, M., Diamond, D.M., Branch, B.J., Heman, K.L., and Rose, G.M., Development of an intact blood-brain barrier in brain tissue transplants is dependent on the site of transplantation, Cell Transplant, 5(2), 305, 1996.
35. Hurst, R.D., Heales, S.J., Dobbie, M.S., Barker, J.E., and Clark, J.B., Decreased endothelial cell glutathione and increased sensitivity to oxidative stress in an in vitro blood-brain barrier model system, Brain Res., 802(1-2), 232, 1998.
36. Martel, C.L., Mackic, J.B., Adams, J.D., Jr., McComb, J.G., Weiss, M.H., and Zlokovic, B.V., Transport of dopamine at the blood-brain barrier of the guinea pig: Inhibition by psychotropic drugs and nicotine, Pharm. Res., 13(2), 290, 1996.
37. Harik, S.I., MPTP toxicity and the “biochemical” blood-brain barrier, NIDA Res. Monogr., 120, 43, 1992.
38. Sarmento, A., Borges, N., and Lima, D., Influence of electrical stimulation of locus coeruleus on the rat blood-brain barrier permeability to sodium fluorescein, Acta Neurochir., 127(3-4), 215, 1994.
39. Borges, N., Shi, F., Azevedo, I., and Audus, K.L., Changes in brain microvessel endothelial cell monolayer permeability induced by adrenergic drugs, Eur. J. Pharmacol., 269(2), 243, 1994.
40. Galea, E. and Estrada, C., Periendothelial acetylcholine synthesis and release in bovine cerebral cortex capillaries, J. Cereb. Blood Flow Metab., 11(5), 868, 1991.
41. Estrada, C., Triguero, D., Munoz, J., and Sureda, A., Acetylcholinesterase-containing fibers and choline acetyltransferase activity in isolated cerebral microvessels from goats, Brain Res., 453(1-2), 275, 1988.
42. Luiten, P.G., de Jong, G.I., Van der Zee, E.A., and van Dijken, H., Ultrastructural localization of cholinergic muscarinic receptors in rat brain cortical capillaries, Brain Res., 720(1-2), 225, 1996.
43. Mohr, E., Subcellular RNA compartmentalization, Prog. Neurobiol., 57(5), 507, 1999.
44. Kaufer, D., Friedman, A., Seidman, S., and Soreq, H., Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission, Chem. Biol. Interact., 119-120, 1999.
45. Powell, H.C., Braheny, S.L., Myers, R.R., Rodriguez, M., and Lampert, P.W., Early changes in experimental allergic neuritis, Lab. Invest., 48(3), 332, 1983.
46. Seeldrayers, P.A., Yasui, D., Weiner, H.L., and Johnson, D., Treatment of experimental allergic neuritis with nedocromil sodium, J. Neuroimmunol., 25(2-3), 221, 1989.
47. Brosnan, C.F., Claudio, L., Tansey, F.A., and Martiney, J., Mechanisms of autoimmune neuropathies, Ann. Neurol., 27(Suppl), S75, 1990.
48. Theoharides, T.C., Spanos, C., Pang, X., Alferes, L., Ligris, K., Letourneau, R., Rozniecki, J.J., Webster, E., and Chrousos, G.P., Stress-induced intracranial mast cell degranulation: A corticotropin-releasing hormone-mediated effect, Endocrinology, 136(12), 5745, 1995.
49. Guo, Z., Turner, C., and Castle, D., Relocation of the t-SNARE SNAP-23 from lamellipodia- like cell surface projections regulates compound exocytosis in mast cells, Cell, 94(4), 537, 1998.
50. Goldschmidt, R.C., Hough, L.B., and Glick, S.D., Rat brain mast cells: Contribution to brain histamine levels, J. Neurochem., 44(6), 1943, 1985.
51. Silver, R., Silverman, A.J., Vitkovic, L., and Lederhendler, I., Mast cells in the brain: Evidence and functional significance, Trends Neurosci., 19(1), 25, 1996.
52. Zhuang, X., Silverman, A.J., and Silver, R., Distribution and local differentiation of mast cells in the parenchyma of the forebrain, J. Comp. Neurol., 408(4), 477, 1999.
53. Silverman, A.-J., Sutherland, A.K., Wilhelm, M., and Silver, R., Mast cells migrate from blood to brain, J. Neurosci., 20(1), 401, 2000.
54. Stewart, P.A. and Wiley, M.J., Developing nervous tissue induces formation of bloodbrain barrier characteristics in invading endothelial cells: A study using quail-chick transplantation chimeras, Dev. Biol., 84(1), 183, 1981.
55. Rubin, L.L., Hall, D.E., Porter, S., Barbu, K., Cannon, C., Horner, H.C., Janatpour, M., Liaw, C.W., Manning, K., Morales, J., et al., A cell culture model of the blood-brain barrier, J. Cell. Biol., 115(6), 1725, 1991.
56. Hurst, R.D. and Fritz, I.B., Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood-brain barrier, J. Cell Physiol., 167(1), 81, 1996.
57. Plateel, M., Dehouck, M.P., Torpier, G., Cecchelli, R., and Teissier, E., Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer, J. Neurochem., 65(5), 2138, 1995.
58. Friedman, A., Kaufer, D., Shemer, J., Hendler, I., Soreq, H., and Tur-Kaspa, I., Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response, Nat. Med., 2(12), 1382, 1996.
59. Sage, M.R., Wilson, A.J., and Scroop, R., Contrast media and the brain. The basis of CT and MR imaging enhancement, Neuroimaging Clin. N. Am., 8(3), 695, 1998.
60. Meijer, O.C., de Lange, E.C., Breimer, D.D., de Boer, A.G., Workel, J.O., and de Kloet, E.R., Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice, Endocrinology, 139(4), 1789, 1998.
61. Powell, H.C., Garrett, R.S., Brett, F.M., Chiang, C.S., Chen, E., Masliah, E., and Campbell, I.L., Response of glia, mast cells and the blood-brain barrier, in transgenic mice expressing interleukin-3 in astrocytes, an experimental model for CNS demyelination, Brain Pathol., 9(2), 219, 1999.
62. Brett, F.M., Mizisin, A.P., Powell, H.C., and Campbell, I.L., Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes, J. Neuropathol. Exp. Neurol., 54(6), 766, 1995.
63. Chan, P.H., Epstein, C.J., Li, Y., Huang, T.T., Carlson, E., Kinouchi, H., Yang, G., Kamii, H., Mikawa, S., Kondo, T., et al., Transgenic mice and knockout mutants in the study of oxidative stress in brain injury, J. Neurotrauma, 12(5), 815, 1995.
64. Mikawa, S., Kinouchi, H., Kamii, H., Gobbel, G.T., Chen, S.F., Carlson, E., Epstein, C.J., and Chan, P. H., Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice, J. Neurosurg., 85(5), 885, 1996.
65. Banks, W.A., Uchida, D., Arimura, A., Somogyvari-Vigh, A., and Shioda, S., Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons, Ann. NY Acad. Sci., 805, 270, 1996.
66. Staddon, J.M., Smales, C., Schulze, C., Esch, F.S., and Rubin, L.L., p120, a p120-related protein (p100), and the cadherin/catenin complex, J. Cell Biol., 130(2), 369, 1995.
67. O’Donnell, M.E., Martinez, A., and Sun, D., Endothelial Na-K-Cl cotransport regulation by tonicity and hormones: Phosphorylation of cotransport protein, Am. J. Physiol., 269(6 Pt 1), C1513, 1995.
68. Jaworowicz, D.J., Jr., Korytko, P.J., Singh Lakhman, S., and Boje, K.M., Nitric oxide and prostaglandin E2 formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis, Brain Res. Bull., 46(6), 541, 1998.
69. Boje, K.M., Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis, Brain Res., 720(1-2), 75, 1996.
70. Federici, C., Camoin, L., Creminon, C., Chaverot, N., Strosberg, A.D, and Couraud, P.O., Cultured astrocytes release a factor that decreases endothelin-1 secretion by brain microvessel endothelial cells, J. Neurochem., 64(3), 1008, 1995.
71. O’Donnell, M.E., Martinez, A., and Sun, D., Cerebral microvascular endothelial cell Na-K-Cl cotransport: Regulation by astrocyte-conditioned medium, Am. J. Physiol., 268(3 Pt 1), C747, 1995.
72. Black, K.L., Biochemical opening of the blood-brain barrier, Adv. Drug Deliv. Rev., 15, 37, 1995.
73. Van Itallie, C.M., Balda, M.S., and Anderson, J.M., Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells, J. Cell Sci., 108(Pt 4), 1735, 1995.
74. Stitt, J.T., Passage of immunomodulators across the blood-brain barrier, Yale J. Biol. Med., 63(2), 121, 1990.
75. Lassmann, H., Basic mechanisms of brain inflammation, J. Neural Transm. Suppl., 50, 183, 1997.
76. Qin, Y. and Sato, T.N., Mouse multidrug resistance 1a/3 gene is the earliest known endothelial cell differentiation marker during blood-brain barrier development, Dev. Dyn., 202(2), 172, 1995.
77. Akeson, P., Larsson, E.M., Kristoffersen, D.T., Jonsson, E., and Holtas, S., Brain metastases- comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging, Acta Radiol., 36(3), 300, 1995.
78. Cornford, E.M. and Oldendorf, W.H., Epilepsy and the blood-brain barrier, Adv. Neurol., 44, 787, 1986.
79. Correale, J., Rabinowicz, A.L., Heck, C.N., Smith, T.D., Loskota, W.J., and DeGiorgio, C.M., Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier, Neurology, 50(5), 1388, 1998.
80. Klatzo, I., Disturbances of the blood-brain barrier in cerebrovascular disorders, Acta Neuropathol. Suppl., 8, 81, 1983.
81. Larsson, H.B., Stubgaard, M., Frederiksen, J.L., Jensen, M., Henriksen, O., and Paulson, O.B., Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors, Magn. Reson. Med., 16(1), 117, 1990.
82. Merten, C.L., Knitelius, H.O., Assheuer, J., Bergmann-Kurz, B., Hedde, J.P., and Bewermeyer, H., MRI of acute cerebral infarcts, increased contrast enhancement with continuous infusion of gadolinium, Neuroradiology, 41(4), 242, 1999.
83. Siegal, T., Sandbank, U., Gabizon, A., Mizrachi, R., Ben-David, E., and Catane, R., Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study, J. Neurooncol., 4(3), 233, 1987.
84. Skoog, I., A review on blood pressure and ischaemic white matter lesions, Dement. Geriatr. Cogn. Disord., 9, Suppl 1, 13, 1998.
85. Menegon, A., Board, P.G., Blackburn, A.C., Mellick, G.D., and Le Couteur, D.G., Parkinson’s disease, pesticides, and glutathione transferase polymorphisms [see Comments], Lancet, 352(9137), 1344, 1998.
86. Loewenstein-Lichtenstein, Y., Schwarz, M., Glick, D., Norgaard-Pedersen, B., Zakut, H., and Soreq, H., Genetic predisposition to adverse consequences of anti-cholinesterases in ‘atypical’ BCHE carriers, Nat. Med., 1(10), 1082, 1995.
87. Soreq, H. and Glick, D., Novel roles for cholinesterases in stress and inhibitor responses, in Cholinesterases and Cholinesterase Inhibitors: Basic, Preclinical and Clinical Aspects, Giacobini, E., ed., Martin Dunitz, Ltd., London, 47-61, 2000.
88. Kuhn, W., Winkel, R., Woitalla, D., Meves, S., Przuntek, H., and Muller, T., High prevalence of Parkinsonism after occupational exposure to lead-sulfate batteries, Neurology, 50(6), 1885, 1998.
89. Rosenberg, G.A., Dencoff, J.E., Correa, N., Jr., Reiners, M., and Ford, C.C., Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: Relation to blood-brain barrier injury, Neurology, 46(6), 1626, 1996.
90. McFarland, H.F., The lesion in multiple sclerosis: Clinical, pathological, and magnetic resonance imaging considerations, J. Neurol. Neurosurg. Psychiatry, 64, Suppl 1, S26, 1998.
91. Stone, L.A., Smith, M.E., Albert, P.S., Bash, C.N., Maloni, H., Frank, J.A., and McFarland, H.F., Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: Relationship to course, gender, and age, Neurology, 45(6), 1122, 1995.
92. Clarke, H.B. and Gabrielsen, T.O., Seizure induced disruption of blood-brain barrier demonstrated by CT, J. Comput. Assist. Tomogr., 13(5), 889, 1989.
93. Oztas, B. and Kucuk, M., Intracarotid hypothermic saline infusion: A new method for reversible blood-brain barrier disruption in anesthetized rats, Neurosci. Lett., 190(3), 203, 1995.
94. Hachinski, V. and Munoz, D.G., Cerebrovascular pathology in Alzheimer’s disease: Cause, effect or epiphenomenon?, Ann. N.Y. Acad. Sci., 826, 1, 1997.
95. Blanc, E.M., Toborek, M., Mark, R.J., Hennig, B., and Mattson, M.P., Amyloid betapeptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells, J. Neurochem., 68(5), 1870, 1997.
96. Jancso, G., Domoki, F., Santha, P., Varga, J., Fischer, J., Orosz, K., Penke, B., Becskei, A., Dux, M., and Toth, L., Beta-amyloid (1 -42) peptide impairs blood-brain barrier function after intracarotid infusion in rats, Neurosci. Lett., 253, 139, 1998.
97. Epstein, L.G. and Gelbard, H.A., HIV-1-induced neuronal injury in the developing brain, J. Leukoc. Biol., 65(4), 453, 1999.
98. Shinnou, M., Ueno, M., Sakamoto, H., and Ide, M., Blood-brain barrier damage in reperfusion following ischemia in the hippocampus of the Mongolian gerbil brain, Acta Neurol. Scand., 98(6), 406, 1998.
99. Lo, E.H., Pan, Y., Matsumoto, K., and Kowall, N.W., Blood-brain barrier disruption in experimental focal ischemia: Comparison between in vivo MRI and immunocytochemistry, Magn. Reson. Imaging, 12(3), 403, 1994.
100. Murakami, K., Kondo, T., Yang, G., Chen, S.F., Morita-Fujimura, Y., and Chan, P.H., Cold injury in mice: A model to study mechanisms of brain edema and neuronal apoptosis, Prog. Neurobiol., 57(3), 289, 1999.
101. Urakawa, M., Yamaguchi, K., Tsuchida, E., Kashiwagi, S., Ito, H., and Matsuda, T., Blood-brain barrier disturbance following localized hyperthermia in rats, Int. J. Hypertherm., 11(5), 709, 1995.
102. Sharma, H.S., Westman, J., Cervos-Navarro, J., and Nyberg, F., Role of neurochemicals in brain edema and cell changes following hyperthermic brain injury in the rat, Acta Neurochir. Suppl., 70, 269, 1997.
103. Carpentier, P., Delamanche, I.S., Le Bert, M., Blanchet, G., and Bouchaud, C., Seizurerelated opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats, Neurotoxicology, 11(3), 493, 1990.
104. Alm, P., Sharma, H.S., Hedlund, S., Sjoquist, P.O., and Westman, J., Nitric oxide in the pathophysiology of hyperthermic brain injury. Influence of a new anti-oxidant compound H-290/51. A pharmacological study using immunohistochemistry in the rat, Amino Acids, 14(1-3), 95, 1998.
105. Chen, Y., Constantini, S., Trembovler, V., Weinstock, M., and Shohami, E., An experimental model of closed head injury in mice: Pathophysiology, histopathology, and cognitive deficits, J. Neurotrauma, 13(10), 557, 1996.
106. Barzo, P., Marmarou, A., Fatouros, P., Corwin, F., and Dunbar, J., Magnetic resonance imaging-monitored acute blood-brain barrier changes in experimental traumatic brain injury, J. Neurosurg., 85(6), 1113, 1996.
107. Petrali, J.P., Maxwell, D.M., Lenz, D.E., and Mills, K.R., Effect of an anticholinesterase compound on the ultrastructure and function of the rat blood-brain barrier: A review and experiment, J. Submicrosc. Cytol. Pathol., 23(2), 331, 1991.
108. Grange-Messent, V., Bouchaud, C., Jamme, M., Lallement, G., Foquin, A., and Carpentier, P., Seizure-related opening of the blood-brain barrier produced by the anticholinesterase compound, soman: New ultrastructural observations, Cell. Mol. Biol. (Noisy-le-grand), 45(1), 1, 1999.
109. Soreq, H. and Zakut, H., Human Cholinesterases and Anticholinesterases, Academic Press, San Diego, 1993.
110. Glikson, M., Achiron, A., Ram, Z., Ayalon, A., Karni, A., Sarova-Pinchas, I., Glovinski, J., and Revah, M., The influence of pyridostigmine administration on human neuromuscular functions-studies in healthy human subjects, Fundam. Appl. Toxicol., 16(2), 288, 1991.
111. Lallement, G., Foquin, A., Baubichon, D., Burckhart, M.F., Carpentier, P., and Canini, F., Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea pigs, Neurotoxicology, 19(6), 759, 1998.
112. Skultetyova, I., Tokarev, D., and Jezova, D., Stress-induced increase in blood-brain barrier permeability in control and monosodium glutamate-treated rats, Brain Res. Bull., 45(2), 175, 1998.
113. Kaufer, D., Friedman, A., and Soreq, H., The vicious circle: Long-lasting transcriptional modulation of cholinergic neurotransmission following stress and anticholinesterase exposure, The Neuroscientist, 5, 173, 1999.
114. Yuekui, L., Li, Y., Liu, L., Kang, J., Sheng, J.G., Barger, S.W., Mrak, R.E., and Griffin, W.S.T., Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression, J. Neurosci., 20(1), 149, 2000.
115. Bourne, Y., Grassi, J., Bougis, P.E., and Marchot, P., Conformational flexibility of the acetylcholinesterase tetramer suggested by x-ray crystallography, J. Biol. Chem., 274(43), 30370, 1999.